Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 August 2022 | Story Samkelo Fetile | Photo Charl Devenish
Gadija Brown MEC for Finance in the Free State
Gadija Brown, Free State MEC for Finance.

Students in the Department of Business Management within the Faculty of Economic and Management Sciences at the University of the Free State (UFS) had the opportunity to attend guest lectures by Gadija Brown, MEC for Finance, and Makalo Mohale, MEC for Economic, Small Business Development, Tourism, and Environmental Affairs (DESTEA) in the Free State government. The guest lectures, which took place on 1 August 2022, were also attended by the Black Management Forum (BMF) Free State Chapter Chair, Mosebetsi Dladla. 

Insights from the guest lecturers

“A priority for the government was SMEs involved in agriculture, tourism, and agricultural industrialisation or manufacturing, as these were the main contributors to the Free State’s economy,” said Brown in her keynote address as she profiled the small business sector of the Free State. 
Makalo Mohale discussed the importance of establishing an enabling environment for the creation of SMEs in the province. “University students, such as the UFS students, can be active participants in the economy by creating businesses that are feasible and viable in order to reduce the unemployment rate of the country, as well as provide employment for themselves,” he said.

Prof Brownhilder Neneh, Head of the Department of Business Management, extended her gratitude to the Free State government representatives for honouring the invitation. She advocated for more interactions and partnerships between the university and provincial government to create a synergy of collaborations between government and academia.

Makalo Mohale MEC Economic, Small Business Development, Tourism, and Environmental Affairs
Makalo Mohale. Photo: Supplied. 


From sit-down exam to practical engagement

The Department of Business Management offers Small Business Management as an undergraduate programme at NQF Level 7 (16 credits) during the third year of study. The module's goal is to give students the knowledge and abilities they need to become capable and self-assured business professionals or leaders.
Dr Ekaete Benedict, Coordinator of the Entrepreneurship and Small Business Management modules, outlined that the group project is what students are assessed on, instead of a sit-down examination. 

“One of the first things I did to change the curricula of the module was to apply for it to become a continuous assessment module,” she said.  “That is, do away with the sit down and write exam component at the end of the semester, and rather test the students on practical engagement with real-life business scenarios and people throughout the duration of the semester,” she continued. 

“This is in line with best practices at the world's top universities,” Dr Benedict concluded.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept